Synovial Sarcoma Overview

Save information for later
Sign Up

Learn About Synovial Sarcoma

What is the definition of Synovial Sarcoma?
Synovial sarcoma is a rare and aggressive soft tissue sarcoma. However, as the tumor grows larger, affected people may notice a lump or swelling. In some cases, the tumor can limit range of motion or cause numbness and/or pain if it presses on nearby nerves. Although Synovial sarcoma does not have a clearly defined cause, genetic factors are believed to influence the development of this disease. Cells in these tumors are usually characterized by the presence of a translocation involving chromosomes X and 18. This translocation is specific to Synovial sarcoma and is often used to diagnose the condition.
What are the alternative names for Synovial Sarcoma?
  • Synovial sarcoma
  • Synovial cell sarcoma
  • Synovialosarcoma
Who are the top Synovial Sarcoma Local Doctors?
Experienced in Synovial Sarcoma
Dr. Rodolfo E. Bordoni
Hematology Oncology
Experienced in Synovial Sarcoma
Dr. Rodolfo E. Bordoni
Hematology Oncology
1100 Johnson Ferry Rd Ste 600, 
Atlanta, GA 
 (2.1 mi)
404-256-4777
Languages Spoken:
English
See accepted insurances

Rodolfo Bordoni is a Hematologist Oncology provider in Atlanta, Georgia. Dr. Bordoni and is rated as an Experienced provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Hodgkin Lymphoma, and Tissue Biopsy.

Advanced in Synovial Sarcoma
Dr. Kamal N. Ummed
Hematology Oncology | Hematology | Oncology
Advanced in Synovial Sarcoma
Dr. Kamal N. Ummed
Hematology Oncology | Hematology | Oncology

Nsh Cancer Institute Professional Services G LLC

1000 Johnson Ferry Rd, 
Atlanta, GA 
 (1.8 mi)
404-851-8000
Languages Spoken:
English, Hindi, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Kamal Ummed is a Hematologist Oncology specialist and a Hematologist in Atlanta, Georgia. Dr. Ummed and is rated as an Advanced provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Adult Soft Tissue Sarcoma, and Alveolar Soft Part Sarcoma. Dr. Ummed is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Synovial Sarcoma
Dr. William T. Reed
Internal Medicine
Experienced in Synovial Sarcoma
Dr. William T. Reed
Internal Medicine

Sandy Springs Internal Medicine, P.C.

755 Mount Vernon Hwy Ne, Suite 500, 
Atlanta, GA 
 (0.7 mi)
678-222-3145
Languages Spoken:
English
See accepted insurances
Accepting New Patients

William Reed is an Internal Medicine provider in Atlanta, Georgia. Dr. Reed and is rated as an Experienced provider by MediFind in the treatment of Synovial Sarcoma. His top areas of expertise are Periorbital Cellulitis, Pectus Carinatum, Cellulitis, and Hypolipoproteinemia. Dr. Reed is currently accepting new patients.

View All Doctors
What are the latest Synovial Sarcoma Clinical Trials?
A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil�) in Patients With Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
A Phase 1 Study of Peposertib (M3814) and Low-Dose Liposomal Doxorubicin (Doxil�) in Patients With Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Drug, Procedure
Study Phase: Phase 1

Summary: This phase I trial tests the safety, side effects, and best dose of combination therapy with liposomal doxorubicin and peposertib in treating patients with sarcoma that has spread from where it first started, to other places in the body (metastatic), or cannot be removed by surgery (unresectable) and for which no known cure is available (advanced). Doxorubicin is in a class of medications called a...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors
A Phase 1/2 Open Label, Basket Study to Assess the Safety, Tolerability and Anti-Tumor Activity of Afamitresgene Autoleucel in Pediatric Subjects With MAGE-A4 Positive Tumors
Enrollment Status: Recruiting
Publish Date: February 26, 2025
Intervention Type: Genetic
Study Phase: Phase 1/Phase 2

Summary: This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-21 years of age with advanced cancers

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center